Ian Sample
Ian Sample is a British journalist. He is employed as Science Editor at The Guardian.1)
COVID-19
On October 16, 2022, the Guardian published an article written by Sample titled “Vaccines to treat cancer possible by 2030, say BioNTech founders”.2) The piece discussed BioNTech's plans to return its focus to developing mRNA-based cancer vaccines, basing itself on the supposed “success” of the COVID-19 vaccines rolled out rapidly in 2020 through 2022.3) Explaining the mechanism of action for the shots, Sample wrote “An mRNA Covid vaccine works by ferrying the genetic instructions for harmless spike proteins on the Covid virus into the body.”
However, by October 18, the article had been quietly updated to read “An mRNA Covid vaccine works by ferrying the genetic instructions for essentially harmless spike proteins on the Covid virus into the body.”4)
1)
Ian Sample. (2019, December). The Guardian. https://web.archive.org/web/20221019045704/https://www.theguardian.com/profile/iansample
2)
Sample, I. (2022, October 16). Vaccines to treat cancer possible by 2030, say BioNTech founders. The Guardian. http://archive.today/2022.10.16-205648/https://www.theguardian.com/society/2022/oct/16/vaccines-to-treat-cancer-possible-by-2030-say-biontech-founders
3)
Sturgess, L. (2022, October 17). This is terrifying. @BioNTech is claiming that: 1) The #spikeprotein that your cells create from the gene transfer is “harmless”; 2) #cancervaccines will use the same mechanism, but with “cancer antigens”, which “stud the surface of #cancer cells.” Twitter. https://twitter.com/TheLiamSturgess/status/1582128704708546560
4)
Sample, I. (2022b, October 16). Vaccines to treat cancer possible by 2030, say BioNTech founders. The Guardian. https://web.archive.org/web/20221019041502/https://www.theguardian.com/society/2022/oct/16/vaccines-to-treat-cancer-possible-by-2030-say-biontech-founders